Just some of the applications for our platforms
Discovery of modulators of inflammation, innate immunity, and autoimmunity-based disorders.
Developing compounds that target neuroinflammation and neurodegeneration.
Development of biofilm-disrupting compounds as well as novel classes of antibiotics.
Discovery of peptides that modulate the activity of membrane proteins (e.g. GPCRs, solute carrier SLC proteins, and ion channels).